U.S. Markets closed

Analysts Have Raised Their Target Price for VRTX in March

Margaret Patrick
Analysts Have Raised Their Target Price for VRTX in March

How Major Rare Disease Pharma Stocks Are Positioned in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 14.17% for Vertex Pharmaceuticals (VRTX) based on the stock’s